Article Details

Obesity Drugmaker BioAge Seeks $158 Million in IPO, Placement - BNN Bloomberg

Retrieved on: 2024-09-18 21:59:51

Tags for this article:

Click the tags to see associated articles and topics

Obesity Drugmaker BioAge Seeks $158 Million in IPO, Placement - BNN Bloomberg. View article details on hiswai:

Summary

The article details BioAge Labs Inc.'s plan to raise $157.5 million via an IPO and private placement, illustrating its involvement in global markets. The process engages Sofinnova, Citigroup, and other key shareholders, underpinning corporate finance strategies.

Article found on: www.bnnbloomberg.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up